Search

Search Results
Results 13791 - 13800 of 88357 for cancer
  • Dieting may not help cancer patients
    News - 19 Jul 2006
    One study, a meta-analysis of 59 trials, found little evidence that diet is associated with survival or prognosis.
  • Bortezomib extends lung cancer survival
    News - 9 Jun 2006
    Adding the new molecularly targeted agent bortezomib to a standard chemotherapy regimen of gemcitabine and carboplatin prolongs survival in patients with advanced non-small cell lung cancer, according...
  • Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center
    News - 10 May 2006
    Brain tumor specialists at The University of Texas M. D. Anderson Cancer Center are poised on the brink of a new era.
  • Discovery of new human retrovirus
    News - 10 Apr 2006
    Howard Hughes Medical Institute researchers and their colleagues have discovered a new retrovirus in humans that is closely related to a cancer-causing virus found in mice. Their findings describe the...
  • Antibody may reduce or eliminate tumors
    News - 17 Mar 2006
    San Diego State University researcher Roger Sabbadini has brought scientists one step closer to finding a cure for cancer with the creation of an antibody that hinders the growth of tumors by...
  • Low PSA score after radiation can predict prostate cancer return
    News - 15 Mar 2006
    A consortium of prostate cancer experts have discovered, through a clinical investigation, that prostate cancer patients who have a lower prostate specific antigen (PSA) score after radiation therapy...
  • Cervical cancer vaccines in development
    News - 27 Feb 2006
    Two preventative vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline) that work against the Human Papilloma virus (HPV) - a sexually transmitted infection and the primary cause of cervical cancer...
  • Anti-cancer drugs based on platinum
    News - 6 Jan 2006
    Researchers at Virginia Commonwealth University's Massey Cancer Center have created a new platinum-based, anti-cancer agent able to overcome acquired drug resistance by first modifying the way it is...
  • Speed of PSA increase matters more than PSA level
    News - 14 Nov 2005
    In the largest study of its kind to date, Mayo Clinic researchers report that prostate specific antigen (PSA) kinetics, both velocity and doubling time, can be used to predict disease progression and...
  • Introgen's INGN 241 combined with Celebrex kills breast cancer cells
    News - 8 Nov 2005
    Introgen Therapeutics, Inc. today reported the publication of preclinical data demonstrating that INGN 241 works synergistically with celecoxib (Celebrex) marketed by Pfizer to inhibit the growth and...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback